Clinical Trials Browser

Phase 2 × OTHER × Androgen Receptor Antagonists × Clear all

NCT06145308 2026-04-02

Precision Treatment of Recurrent/Metastatic Salivary Gland Carcinoma Guided by Molecular Typing

Phase 2 Recruiting

Salivary Gland Neoplasms

NCT00103376 2018-11-05

Bortezomib With or Without Hormone Therapy in Treating Patients With Relapsed Prostate Cancer

Phase 2 Terminated

23 enrolled 9 charts

Prostatic Neoplasms